Topical corticosteroids

Topical corticosteroids

Drug monograph · NCLEX study reference
Therapeutic class	Anti-inflammatory (skin)
Pharmacologic class	Topical corticosteroids by potency
Onset / peak / duration	Symptom relief within days.
Half-life / level	Local; minimal systemic absorption when used correctly.
High-alert (ISMP)	No
Black box warning	None
Antidote / reversal	Discontinue; supportive skin care.
Pregnancy / lactation	Low-potency use generally acceptable.

Nursing pharmacology study reference (NCLEX-style monograph). Numeric values are standard teaching ranges for study and must be verified against current manufacturer labeling before clinical use. This is educational content, not prescribing guidance.

Topical corticosteroids — Anti-inflammatory (skin); Topical corticosteroids by potency.

Identification

• Therapeutic class: Anti-inflammatory (skin).
• Pharmacologic class: Topical corticosteroids by potency.

Pharmacology

• Mechanism of action: Reduce skin inflammation, itching, and immune response.
• Onset / peak / duration: Symptom relief within days.
• Half-life / therapeutic level: Local; minimal systemic absorption when used correctly.

Clinical use

• Indications: Eczema, dermatitis, psoriasis, inflammatory and pruritic skin conditions.
• Usual dose, route, frequency: Apply a thin layer one to two times daily; potency and duration matched to the area.
• Maximum dose / adjustments: Use the lowest potency that works; limit duration and occlusion; use low potency on the face, groin, and in children.

Safety

• Contraindications: Untreated skin infections, hypersensitivity.
• Black box warning: None.
• Interactions: Minimal topically.
• Pregnancy / lactation: Low-potency use generally acceptable.
• High-alert: No.

Adverse effects

• Common side effects: Burning, dryness, skin thinning with prolonged use.
• Serious effects to report: Skin atrophy, striae, HPA axis suppression (high potency, large areas, occlusion), worsening infection.
• Antidote / reversal: Discontinue; supportive skin care.

Nursing process

• Assessment before administration: Skin condition, area, infection presence.
• Interventions during therapy: Apply thinly; avoid occlusion unless directed; do not use high potency on the face.
• Monitor: Skin response, signs of atrophy or systemic effects.
• Evaluation / expected outcome: Reduced inflammation and itching.

Patient teaching

• Patient teaching: Use a thin layer for the prescribed time; do not cover with airtight dressings unless told; high-potency products are short term.
• Notify provider if: Worsening rash, signs of infection, skin thinning.
• Administration tips: Thin layer; wash hands; match potency to the body area.